Company Filing History:
2 out of 832,912 Years Active: 2003
Title: Erwin Sigel: Innovator in Nervous Disorder Treatments
Introduction
Erwin Sigel is a notable inventor based in Bremgarten, Switzerland. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds aimed at treating nervous disorders. With a total of 2 patents, his work has the potential to impact the pharmaceutical industry significantly.
Latest Patents
Sigel's latest patents include innovative compounds such as N substituted 3-amino-2,2-di-c-alkyl-1,4-butyrolactones and 1,4-thiobutyrolactones. These compounds are designed for use as promoters of γ-aminobutyric acid activity and for treating nervous disorders. The invention details compounds represented by a specific general formula, where various groups represent different chemical structures. Additionally, he has developed N-substituted 1-(lactone) isoquinolones, which also target nervous disorders by stimulating γ-aminobutyric acid activity.
Career Highlights
Throughout his career, Erwin Sigel has focused on creating pharmaceutical compositions that contain his innovative compounds. His work emphasizes the preparation methods for these compounds, showcasing his expertise in medicinal chemistry and his commitment to advancing treatment options for nervous disorders.
Collaborations
Sigel has collaborated with notable colleagues, including Robert H. Dodd and Werner Sieghart. These partnerships have likely contributed to the depth and breadth of his research and innovations.
Conclusion
Erwin Sigel's contributions to the field of medicinal chemistry, particularly in the treatment of nervous disorders, highlight his role as an influential inventor. His innovative patents and collaborative efforts continue to pave the way for advancements in pharmaceutical treatments.